Delivery Order SPE2DB22D3016-SPE2DB25FAJK2

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply DIFICID 200 MG TABLET 20S. The contract has a firm fixed price ceiling value of $31,559.64 and an ultimate completion date of August 27, 2024. This order is not associated with a set-aside program. AmerisourceBergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DIFICID 200 MG TABLET 20S. The contract has a ceiling value of $19,227.56 and an ultimate completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement, and there was no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DIFICID 200 MG TABLET 20S. The firm-fixed-price contract is valued at $8,101.92 and has a period of performance through November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,422.90, is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of May 8, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,297.44 firm fixed-price contract is for the delivery of DIFICID 200 MG TABLET 20S. The award has an ultimate completion date of April 17, 2023. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIFICID 200 MG TABLET 20S, with a ceiling value of $8,772.04 and a completion date of October 13, 2023. The contract is a Firm Fixed Price type and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,643.04, is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2024 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the drug DIFICID 200 MG TABLET 20S. The contract has a ceiling value of $3,247.15 and a period of performance ending on July 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200 mg DIFICID tablets. The $6,932.80 firm fixed-price contract has a completion date of September 10, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of DIFICID 200 MG TABLET 20S. The $3,217.73 firm fixed-price contract has an ultimate completion date of April 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAJK2
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DIFICID 200 MG TABLET 20S, with a ceiling value of $16,278.36 and a performance period through January 8, 2025. The contract does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/8/25, 9:46 AM